{"id":"W3026889703","doi":"10.1016/j.jval.2020.04.220","title":"PDB32 COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE 1 MG VS. CANAGLIFLOZIN 300 MG IN PATIENTS WITH TYPE 2 DIABETES IN A CANADIAN SETTING","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Semaglutide; Medicine; Type 2 diabetes; Cost effectiveness; Quality-adjusted life year; Metformin; Dapagliflozin; Type 2 Diabetes Mellitus; Internal medicine; Diabetes mellitus; Endocrinology; Insulin; Liraglutide; Risk analysis (engineering)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008051781,0.0005933837,0.001499416,0.0005630747,0.0008097975,0.001470799,0.0009142564,0.0009861458,0.006365992],"category_scores_gemma":[0.003658842,0.0003013708,0.003235237,0.001178743,0.0004541019,0.0005975247,0.0005885179,0.00153722,0.0002439056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02937303,"about_ca_system_score_gemma":0.02833409,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8480564,"about_ca_topic_score_gemma":0.876064,"domain_scores_codex":[0.9991482,0.0001924968,0.00004994014,0.0001172656,0.0001895527,0.0003025141],"domain_scores_gemma":[0.9986629,0.0002624968,0.0001775258,0.00003339829,0.0002095831,0.0006540886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5252443,0.006154487,0.09344416,0.002962441,0.007125797,0.0005496698,0.0002988896,0.02995807,0.002016554,0.004278591,0.03613431,0.2918328],"study_design_scores_gemma":[0.146289,0.04322807,0.681546,0.002804087,0.02297524,0.0009703691,0.002108562,0.07565399,0.001725454,0.003262981,0.01875785,0.0006783927],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9581788,0.01627688,0.000266976,0.004405052,0.0003796014,0.000391757,0.006173614,0.00007812658,0.01384923],"genre_scores_gemma":[0.9947886,0.001716865,0.0003915673,0.0003726547,0.00006086892,0.00004383759,0.001458614,0.000009013424,0.001157933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1519436,"threshold_uncertainty_score":0.3056769,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02404620495398717,"score_gpt":0.2674188494305264,"score_spread":0.2433726444765392,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}